Oral Anticoagulation After Atrial Fibrillation Ablation: An Updated Systematic Review and Meta‐Analysis of 267 443 Patients

Discontinuation of OAC after successful AF ablation markedly reduces MBE without a statistically significant increase in TE, highlighting the need for individualized post-ablation anticoagulation strategies. Randomized trials are needed to confirm the safety of tailored oral anticoagulant discontinuation in selected patients, supported by careful long-term follow-up and shared decision-making.